zdenÄ›k kejĂk
First Faculty of Medicine, Charles University
Prague, Czechia
Associate Editor
Pharmacology of Anti-Cancer Drugs
First Faculty of Medicine, Charles University
Prague, Czechia
Associate Editor
Pharmacology of Anti-Cancer Drugs
LMU Munich University Hospital
Munich, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Medical University of Vienna
Vienna, Austria
Associate Editor
Cancer Metabolism
University of Michigan
Ann Arbor, United States
Associate Editor
Cancer Immunity and Immunotherapy
Michigan Medicine, University of Michigan
Ann Arbor, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Toronto
Toronto, Canada
Associate Editor
Cancer Epidemiology and Prevention
Dongguk University Seoul
Seoul, Republic of Korea
Associate Editor
Cancer Epidemiology and Prevention
University of Colorado Anschutz Medical Campus
Aurora, United States
Associate Editor
Molecular and Cellular Oncology
Sanofi (France)
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
National Cancer Institute, Cairo University
Cairo, Egypt
Associate Editor
Genitourinary Oncology
Barbara Ann Karmanos Cancer Institute, School of Medicine, Wayne State University
Detroit, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
National Institutes of Health (NIH)
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Hail
Ha'il, Saudi Arabia
Associate Editor
Cancer Immunity and Immunotherapy
The University of Texas Rio Grande Valley
Edinburg, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Hämatologie und Onkologie
LĂĽbeck, Germany
Associate Editor
Hematologic Malignancies
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology